IDEXX Laboratories Announces Third Quarter Results : vimarsa

Achieves third quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 10% reported and 9% organic



Solid revenue growth reflects benefits from...

Related Keywords

Japan , United Kingdom , Maine , United States , Canada , China , Australia , Brazil , Chinese , Brazilian , Australian , Japanese , America , British , Canadian , Jay Mazelsky , Foreign Currency Exchange Rate Impacts , Company Quarterly Reports On Form , Forward Foreign Currency Exchange Rate Assumptions , Nasdaq , Laboratories Inc , Companion Animal Group , Service Categories , Company Annual Report On Form , Exchange Commission , Chief Executive , Financial Performance , Recurring Revenue , Private Securities Litigation Reform Act , Financial Condition , Qualitative Disclosures About Market , Annual Report , Quarterly Reports , Financial Performance Outlook , Compensation Stock , Employee Share Based Payment Accounting , Leverage Ratios , Quarterly Report , Consolidated Statement , Operating Information , Revenue Growth Analysis , Statements Regarding , Balance Sheet Information , Operating Activities , Investing Activities , Financing Activities , Cash Flow , Markets ,